Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma

Hideko Ohama, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Takeshi Hatanaka, Joji Tani, Koichi Takaguchi, Masanori Atsukawa, Ei Itobayashi, Takashi Nishimura, Kunihiko Tsuji, Kazuto Tajiri, Toru Ishikawa, Satoshi Yasuda, Hidenori Toyoda, Shinya Fukunishi, Chikara Ogawa, Satoru Kakizaki, Noritomo Shimada, Atsushi Naganuma, Kazuhito Kawata, Hisashi Kosaka, Hidekatsu Kuroda, Tomomitsu Matono, Yutaka Yata, Hironori Ochi, Fujimasa Tada, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Keisuke Yokohama, Hiroki Nishikawa, Michitaka Imai, Yohei Koizumi, Shinichiro Nakamura, Hiroko Iijima, Masaki Kaibori, Yoichi Hiasa, Takashi Kumada, Unknown

Open source

DOI: 10.1002/cnr2.2042
Published: 2024-04
Container: Cancer Reports
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cnr2.2042,
  title = {Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma},
  author = {Hideko Ohama and Atsushi Hiraoka and Toshifumi Tada and Masashi Hirooka and Kazuya Kariyama and Takeshi Hatanaka and Joji Tani and Koichi Takaguchi and Masanori Atsukawa and Ei Itobayashi and Takashi Nishimura and Kunihiko Tsuji and Kazuto Tajiri and Toru Ishikawa and Satoshi Yasuda and Hidenori Toyoda and Shinya Fukunishi and Chikara Ogawa and Satoru Kakizaki and Noritomo Shimada and Atsushi Naganuma and Kazuhito Kawata and Hisashi Kosaka and Hidekatsu Kuroda and Tomomitsu Matono and Yutaka Yata and Hironori Ochi and Fujimasa Tada and Kazuhiro Nouso and Asahiro Morishita and Norio Itokawa and Tomomi Okubo and Taeang Arai and Akemi Tsutsui and Takuya Nagano and Keisuke Yokohama and Hiroki Nishikawa and Michitaka Imai and Yohei Koizumi and Shinichiro Nakamura and Hiroko Iijima and Masaki Kaibori and Yoichi Hiasa and Takashi Kumada and Unknown},
  year = {2024},
  journal = {Cancer Reports},
  doi = {10.1002/cnr2.2042},
  url = {https://doi.org/10.1002/cnr2.2042}
}

RIS

TY  - JOUR
TI  - Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma
AU  - Hideko Ohama
AU  - Atsushi Hiraoka
AU  - Toshifumi Tada
AU  - Masashi Hirooka
AU  - Kazuya Kariyama
AU  - Takeshi Hatanaka
AU  - Joji Tani
AU  - Koichi Takaguchi
AU  - Masanori Atsukawa
AU  - Ei Itobayashi
AU  - Takashi Nishimura
AU  - Kunihiko Tsuji
AU  - Kazuto Tajiri
AU  - Toru Ishikawa
AU  - Satoshi Yasuda
AU  - Hidenori Toyoda
AU  - Shinya Fukunishi
AU  - Chikara Ogawa
AU  - Satoru Kakizaki
AU  - Noritomo Shimada
AU  - Atsushi Naganuma
AU  - Kazuhito Kawata
AU  - Hisashi Kosaka
AU  - Hidekatsu Kuroda
AU  - Tomomitsu Matono
AU  - Yutaka Yata
AU  - Hironori Ochi
AU  - Fujimasa Tada
AU  - Kazuhiro Nouso
AU  - Asahiro Morishita
AU  - Norio Itokawa
AU  - Tomomi Okubo
AU  - Taeang Arai
AU  - Akemi Tsutsui
AU  - Takuya Nagano
AU  - Keisuke Yokohama
AU  - Hiroki Nishikawa
AU  - Michitaka Imai
AU  - Yohei Koizumi
AU  - Shinichiro Nakamura
AU  - Hiroko Iijima
AU  - Masaki Kaibori
AU  - Yoichi Hiasa
AU  - Takashi Kumada
AU  - Unknown
PY  - 2024
JO  - Cancer Reports
DO  - 10.1002/cnr2.2042
UR  - https://doi.org/10.1002/cnr2.2042
ER  -

APA

Ohama, H., Hiraoka, A., Tada, T., Hirooka, M., Kariyama, K., Hatanaka, T., Tani, J., Takaguchi, K., Atsukawa, M., Itobayashi, E., Nishimura, T., Tsuji, K., Tajiri, K., Ishikawa, T., Yasuda, S., Toyoda, H., Fukunishi, S., Ogawa, C., Kakizaki, S., Shimada, N., Naganuma, A., Kawata, K., Kosaka, H., Kuroda, H., Matono, T., Yata, Y., Ochi, H., Tada, F., Nouso, K., Morishita, A., Itokawa, N., Okubo, T., Arai, T., Tsutsui, A., Nagano, T., Yokohama, K., Nishikawa, H., Imai, M., Koizumi, Y., Nakamura, S., Iijima, H., Kaibori, M., Hiasa, Y., Kumada, T., & Unknown (2024). Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma. Cancer Reports. https://doi.org/10.1002/cnr2.2042

Source records

crossref · retrieved 2026-09-27T11:44:57.837Z